APA

Yamada A., Noguchi M., Komatsu N., Suekane S., Yutani S., Moriya F., Mine T., Momozono K., Kawano K. & Itoh K. (2011). Phase I clinical study of a personalized peptide vaccination available for six different human leukocyte antigen (HLA-A2, -A3, -A11, -A24, -A31 and -A33)-positive patients with advanced cancer. : Experimental and therapeutic medicine.

Chicago

Yamada Akira, Noguchi Masanori, Komatsu Nobukazu, Suekane Shigetaka, Yutani Shigeru, Moriya Fukuko, Mine Takashi, Momozono Kosuke, Kawano Koichiro and Itoh Kyogo. 2011. Phase I clinical study of a personalized peptide vaccination available for six different human leukocyte antigen (HLA-A2, -A3, -A11, -A24, -A31 and -A33)-positive patients with advanced cancer. : Experimental and therapeutic medicine.

Harvard

Yamada A., Noguchi M., Komatsu N., Suekane S., Yutani S., Moriya F., Mine T., Momozono K., Kawano K. and Itoh K. (2011). Phase I clinical study of a personalized peptide vaccination available for six different human leukocyte antigen (HLA-A2, -A3, -A11, -A24, -A31 and -A33)-positive patients with advanced cancer. : Experimental and therapeutic medicine.

MLA

Yamada Akira, Noguchi Masanori, Komatsu Nobukazu, Suekane Shigetaka, Yutani Shigeru, Moriya Fukuko, Mine Takashi, Momozono Kosuke, Kawano Koichiro and Itoh Kyogo. Phase I clinical study of a personalized peptide vaccination available for six different human leukocyte antigen (HLA-A2, -A3, -A11, -A24, -A31 and -A33)-positive patients with advanced cancer. : Experimental and therapeutic medicine. 2011.